Physician Care Clinical Research, LLC.

Sarasota, Florida 34329

0 studies enrolling now · 17 studies all time

What they study most

Atrophic Vaginitis, Candida Vulvovaginitis, Cervical Intraepithelial Neoplasia, Chlamydia Trachomatis Infection, Contraception, Endometriosis, Hot Flashes, Human Papillomavirus, Leiomyomas, Mammographic Breast Density, Menopausal Symptoms, Patients With Opioid Induced Constipation

Studies at this site

• A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related Pain — Completed
• Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort Study I) — Completed
• A Study to Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women Going Through Menopause - 2 — Completed
• Study to Evaluate the Equivalence of Estradiol Vaginal Cream to Reference Standard in the Treatment of Vaginal Atrophy — Completed
• Alinity m HR HPV Specimen Collection Study From Women Undergoing Routine Cervical Cancer Screening — Completed
• Trial of 4-Hydroxytamoxifen (4-OHT) Gel in Women Aimed at Reducing Dense Breast Tissue — Stopped early
• Study to Evaluate the Pharmacodynamics and Efficacy of Leuprolide Tablets (Ovarest®) in Women With Endometriosis — Status unconfirmed
• A Comparison of Estradiol Vaginal Cream to Estrace® Cream in 350 Postmenopausal Females With Atrophic Vaginitis — Completed
• Efficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects With Acute Vulvovaginal Candidiasis — Completed
• KYleena Satisfaction Study / Observational Study on User Satisfaction With the Levonorgestrel Intrauterine Delivery System Kyleena (LNG-IUS 12) in New Contraceptive Users and After Switching From Another Contraceptive Method — Completed
• Phase 2B/3 Double-blinded Placebo-controlled — Completed
• A Study to Evaluate Oral VT-1161 in the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection) — Completed
• Longitudinal Study of Patients With Opioid-Induced Constipation — Completed
• Multicenter Study Evaluating the Safety of Proellex® in Premenopausal Women With Uterine Fibroids — Stopped early
• Safety and Efficacy of 25 and 50 mg Doses of Proellex® in Treating the Recurrence of Uterine Fibroid Symptoms — Withdrawn before enrolling
• Efficacy and Safety Study of Ulipristal Acetate in Females With Anemia Associated With Uterine Leiomyoma — Withdrawn before enrolling
• Safety and Efficacy of A-007 Topical Gel in the Treatment of High-Grade Squamous Intraepithelial Lesions (HSIL) of the Cervix — Completed